These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34820749)

  • 1. Kaempferol sensitizes tumor necrosis factor-related apoptosis-inducing ligand-resistance chronic myelogenous leukemia cells to apoptosis.
    Saraei R; Rahman HS; Soleimani M; Asghari-Jafarabadi M; Naimi A; Hassanzadeh A; Solali S
    Mol Biol Rep; 2022 Jan; 49(1):19-29. PubMed ID: 34820749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaempferol Improves TRAIL-Mediated Apoptosis in Leukemia MOLT-4 Cells by the Inhibition of Anti-apoptotic Proteins and Promotion of Death Receptors Expression.
    Hassanzadeh A; Naimi A; Hagh MF; Saraei R; Marofi F; Solali S
    Anticancer Agents Med Chem; 2019; 19(15):1835-1845. PubMed ID: 31364517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5.
    Zhao Y; Tian B; Wang Y; Ding H
    Med Sci Monit; 2017 Oct; 23():5096-5105. PubMed ID: 29070784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.
    Uno K; Inukai T; Kayagaki N; Goi K; Sato H; Nemoto A; Takahashi K; Kagami K; Yamaguchi N; Yagita H; Okumura K; Koyama-Okazaki T; Suzuki T; Sugita K; Nakazawa S
    Blood; 2003 May; 101(9):3658-67. PubMed ID: 12506034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-treatment of birinapant with TRAIL synergistically induces apoptosis by downregulating cFLIP(L) in MDA-MB-453 cell lines.
    Park EJ; Kim HD; Choi EK; Hoe KL; Kim DU
    Biochem Biophys Res Commun; 2020 Dec; 533(3):289-295. PubMed ID: 32958259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP.
    Park SJ; Kim MJ; Kim HB; Kang CD; Kim SH
    Biochem J; 2009 Apr; 420(1):73-81. PubMed ID: 19203346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.
    Yerbes R; López-Rivas A
    Invest New Drugs; 2012 Apr; 30(2):541-7. PubMed ID: 21107885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins.
    Yang L; Wang Q; Li D; Zhou Y; Zheng X; Sun H; Yan J; Zhang L; Lin Y; Wang X
    Apoptosis; 2013 May; 18(5):618-26. PubMed ID: 23371323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
    Rosato RR; Almenara JA; Coe S; Grant S
    Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial effect of curcumin and tumor necrosis factor-α-related apoptosis-inducing ligand (TRAIL) in induction of apoptosis via inhibition of nuclear factor kappa activity and enhancement of caspase-3 activity in chronic myeloid cells: An
    Iqbal B; Ghildiyal A; Singh S; Siddiqui S; Kumari P; Arshad M; Mahdi AA
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1193-S1200. PubMed ID: 30539870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy.
    Vallo S; Stege H; Berg M; Michaelis M; Winkelmann R; Rothweiler F; Cinatl J
    Oncol Rep; 2020 Apr; 43(4):1331-1337. PubMed ID: 32020226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin.
    Siegelin MD; Reuss DE; Habel A; Herold-Mende C; von Deimling A
    Mol Cancer Ther; 2008 Nov; 7(11):3566-74. PubMed ID: 19001439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
    Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
    Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis.
    Yoshida T; Konishi M; Horinaka M; Yasuda T; Goda AE; Taniguchi H; Yano K; Wakada M; Sakai T
    Biochem Biophys Res Commun; 2008 Oct; 375(1):129-33. PubMed ID: 18680719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia.
    Kuroda I; Inukai T; Zhang X; Kikuchi J; Furukawa Y; Nemoto A; Akahane K; Hirose K; Honna-Oshiro H; Goi K; Kagami K; Yagita H; Tauchi T; Maeda Y; Sugita K
    Oncogene; 2013 Mar; 32(13):1670-81. PubMed ID: 22665066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychavicol sensitizes imatinib-resistant chronic myelogenous leukemia cells to TRAIL-induced apoptosis by ROS-mediated IAP downregulation.
    Paul T; Banerjee A; Reddy SVB; Mahato SK; Biswas N
    Anticancer Drugs; 2019 Feb; 30(2):167-178. PubMed ID: 30418193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.
    Han MA; Lee DH; Woo SM; Seo BR; Min KJ; Kim S; Park JW; Kim SH; Choi YH; Kwon TK
    Sci Rep; 2016 Jan; 6():18642. PubMed ID: 26725939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.
    Liu LG; Tanaka H; Ito K; Ito T; Sultana TA; Kyo T; Kimura A
    Acta Haematol; 2005; 113(2):113-23. PubMed ID: 15802890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells.
    Tazzari PL; Tabellini G; Ricci F; Papa V; Bortul R; Chiarini F; Evangelisti C; Martinelli G; Bontadini A; Cocco L; McCubrey JA; Martelli AM
    Cancer Res; 2008 Nov; 68(22):9394-403. PubMed ID: 19010914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression.
    Ding J; Polier G; Köhler R; Giaisi M; Krammer PH; Li-Weber M
    J Biol Chem; 2012 Jan; 287(1):641-649. PubMed ID: 22086925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.